PARTICIPANT PROFILES

Dr. Ferry Siswojo Djongianto was born in 1970 and earned his bachelor degree in Law from Tarumanegara University in 1994. In 1996, he finished his master in Law from University Western Australia. Then he obtained his doctoral degree in Law from Tarumanegara University in 2018.

He started his career as a lawyer at Hanafiah Soeharto Ponggawa (HSP) in Jakarta in 1992-1994 before becoming a consultant at Deacons Graham & James, Perth, Western Australia in 1995. A year later, he moved to PT. Lontar Papyrus Pulp & Paper Industry and became the Director of Corporate & Legal Affairs at Sinarmas Pulp & Paper Group of Companies in 2018. Besides, he has been a Law Lecturer at Tarumanegara University, a member of Advisory Board of PERADI, and an Advisor at Yang & Co. He is currently the Vice President Director of PT. Kura Kura Bali.

Dr. Ian Hudson has a leading role on the team in areas that include optimizing clinical studies and strengthening regulatory systems in Africa and other low-resource regions, particularly for malaria, polio, and COVID-19 drugs.

He was a practicing pediatrician before joining SmithKline Beecham in 1989 to work in research and development. In 2001, he joined the UK government’s Medicines & Healthcare products Regulatory Service (MHRA), where he served as director of licensing and then CEO. Ian was the UK delegate to the scientific committee of the European Medicines Agency’s Management Board, CHMP, later becoming its vice chair. He was also an honorary senior lecturer in clinical pharmacology at the University of London and served as chair of the International Coalition of Medicines Regulatory Authorities.

He earned his medical degree, with a specialty in neonatal hematology, from London Hospital Medical College, and has postgraduate qualifications in pediatrics and pharmaceutical medicine. In 2020, he was awarded an OBE for Services to Healthcare, received a Faculty of Pharmaceutical Medicine President’s medal for contribution to pharmaceutical medicine, and was named a Global Fellow in Medicines Development by the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine.

Dr. John Climax is the co-founder of Afimmune, a biotech specialising in metabolic diseases where he is the CEO, and DS Biopharma, a dermatology biotech where he is Executive Chairman. He is also co-founder of the world leading Clinical Research Organisation (CRO), ICON plc in 1990. He was the previous Chairman and CEO and current non-executive Director of ICON plc. He is a founding member of Science Gallery International and Human Dignity Foundation. He is also affiliated with the boards of a number of private companies, Universities and foundations. He received his primary degree in Pharmacy from the University of Singapore, his Masters in Applied Pharmacology from the University of Wales and his Doctorate in Clinical Pharmacology from the University of Ireland. He was also awarded a Doctorate in Science by Trinity College Dublin. He is Adjunct Professor of Pharmaceutics at the Royal College of Surgeons Ireland and Honorary Professor of Pharmacology and Pharmacy at National University of Singapore. He is also an honorary fellow of St Hilda’s, University of Oxford.

Honesti Basyir is a technocrats, an econom, and a professional who currently is the CEO at PT. Bio Farma. Prior to his current position, he was the CEO at PT. Kimia Farma. Before pivoting his career to pharmaceutical industry, he was the CFO at PT. Telkom Indonesia for 23 years, Vice President Strategic Business Development IT Solution & Strategic Portfolio Department, also Assistant Vice President Business & Finance Analysis and Project Controller-1 Project Management Office. He is an Industrial Engineering graduate of Institute Technology of Bandung who continued his master education in Corporate Finance at the same university.

Dr. Marie Studer is the Senior Program Manager at Planetary Health Alliance who has more than 20 years of scientific and education program and operational experience delivering results for mission-oriented organizations supporting sustainable community development and audience engagement. She earned her Bachelor of Arts in Chemistry from Wheaton College Massachusetts and PhD in Environmental Science from UMass Boston.

Her career has focused on public accessibility and understanding of science through government and public policy positions, to scientific and education leadership for international citizen science projects, to engaging formal and informal educators and youth in biodiversity learning using hands-on and online resources and tools.

Marie has executive leadership experience in non-profit organizations and multi-institutional consortiums, with a proven record in strategic planning, strategic partnership development, organizational management and development, budgeting, fiscal control, staff development, stakeholder relations, and fundraising. She has held positions as Staff Scientist for the Massachusetts Bays National Estuary Program, Chief Scientist for Earthwatch Institute, and as Director of Learning + Education for the Encyclopedia of Life (EOL). She serves on several boards and committees for organizations working to support sustainable communities and environments.

He attended the prestigious University of Kerala, India where he graduated with a Bachelor of Science in Physics, Mathematics, and Chemistry. It has helped to pave the way for him to secure a career in the pharmaceutical industry and as an entrepreneur. Besides his love for science, having a true passion in creating and driving value through business motivated him to pursue his post-graduation in Business Administration from the University of Calicut, India in 1978. This led to a whirlwind of a professional career that eventually brought him to Singapore in 2006. He was well aware of the career and business opportunities he will be presented with in Singapore, as it is the financial hub for business in Asia. Afterwards, he decided to take over the operations as CEO & Managing Director when his organisation acquired a Singapore based Pharma company. He is currently the Chairman of Life Sciences Industry Group at Singapore Manufacturing Federation and an International Council Member of National University of Singapore.

Niclas Adler is a Swedish entrepreneur, scientist, founder and CEO for Synthesis Group. As an entrepreneur, he has built several biopharma and medical technology companies as well as both VC and PE funds dedicated to life-sciences. Adler obtained his MBA at the Stockholm School of Economics in 1994, where in 1999 he also obtained his PhD. His academic career started both at Stockholm School of Economics and the Chalmers University of Technology in 1994, where he was Associate Professor and Director of FENIX until 2005. In cooperation with the Stockholm School of Economics in 1996 he co-founded its Center for Management Innovations, and was Program Director and Fellow until 2005. In 1998 he also co-founded the Stockholm School of Entrepreneurship. Since 2007, he has been a professor of several business schools, science institute, and college in Stockholm, United States, and Indonesia. In addition, he have co-founded 25 technology, compute and innovation-based companies, and he is chairman and board members in several technology and innovation based companies.

Astrid Dita has Bachelor of Science of Pharmaceutical Sciences from Institute Technology of Bandung and Master of Arts in Economics from University of Indonesia. Before joining Tony Blair Institute for Global Change as a Senior E- Government Advisor, she has worked as a public finance analyst at The World Bank, policy advisor, researcher, and consultant for more than 10 years. She is an economist with interests on public finance, infrastructure (particularly PPP financing scheme), fiscal decentralization, and regional economy (particularly ASEAN+3).

Budi Legowo is the CFO of PT. Pertamina Bina Medika IHC and the President Commissioner of PT. Gunung Raja Paksi, Tbk. Before, he was the CFO of Siloam Hospitals Group. He has Bachelor of Engineering in Chemical Engineering from Institute Technology of Bandung and MBA from The University of Chicago Booth School of Business.

Charles Honoris was born in 1984 and he is a member of the Indonesian House of Representatives from PDI-P. Currently he is serving at Commission I of the House of Representatives overseeing Defence, Foreign Affairs, Intelligence, Communications and Informations. He was educated in political science at the International Christian University in Japan. He has been an active writer since his college days on issues related to politics, human rights and international relations published in several Indonesian national media. He is the son of Luntungan Honoris, the founder of Modern Group that has several line of businesses, including otomotive (Foton), property (Modernland Realty), retail store chain (Seven Eleven), and photo printing (Fuji Film).

Kristiarto Legowo born in 1962 and currently is the Indonesian Ambassador to Australia. He completed the full course of international relations of Faculty of Politics and Social Sciences at University of Gadjah Mada and graduated with a doctorate degree. He started his career as a young staffer into the Ministry of Foreign Affairs in 1987. Then subsequently, to gain professional experience, he moved through various positions in the Ministry. As a career diplomat, he has held a series of positions within the Ministry including Director for Public Diplomacy, Chief Staff and Spokesperson for Foreign Minister Hassan Wirajuda, Director for East Asian and Paci? c Affairs, and Secretary General of the Ministry. Before his posting as Ambassador to Australia, his overseas assignments included positions in Vatican, United States, Australia, and Philippines.

Andrew Ang is the Managing Director of Vizzio Technologies, a technology company that combines advanced 3D visualisation technologies, A. I. machine learning processes, and Edge-Computing scanning hardware, bringing together an advanced yet easy-to-use platform designed for highly accurate and immersive 3D capture & visualisations. He earned his MBA at University of Hull and PhD. in International Business, Corporate Strategy at University of South Australia. In addition, he also took the Advanced Management Programme at INSEAD. He is a senior executive with over 25 years of regional sales, marketing, consulting and strategy development experience leading business & digital transformation for MNCs, government agency, and start-ups across Asia. He has expatriated to USA, London, Barcelona and Shanghai and consulted on development and deployments of AI & ML SaaS for tier one banks and insurers since 2016.

David Goodwins has a science degree from University of Adelaide, a Master’s degree in Business and Technology from the University of NSW, and a Graduate Certi? cate in Program Evaluation from the University of Melbourne. He is now the Lead Adviser at IA-CEPA ECP Katalis, a unique, ?ve year (2021-25) government-backed business development program unlocking the vast potential of economic partnership between Australia and Indonesia. Previously, he worked for more than 14 years and his latest position is as a senior principal for Coffey International Development (now a Tetra Tech Company). He also has over 30 years’ experience in research, monitoring and evaluation supporting a range of development programs, urban and regional planning, and environmental management outcomes.

David Ho is an AIDS researcher, physician, and virologist who has made a number of scienti? c contributions to the understanding and treatment of HIV infection. He received his Bachelor of Science in biology and MD from the Harvard-MIT Division of Health Sciences and Technology. Subsequently, he did his clinical training in internal medicine and infectious diseases at UCLA School of Medicine and Massachusetts General Hospital. He was a resident in internal medicine at Cedars-Sinai Medical Center in Los Angeles in 1981 when he came into contact with some of the ?rst reported cases of what was later identi? ed as AIDS. In the mid 1990s, his research team conducted a series of elegant human studies to elucidate the dynamics of HIV replication in vivo which was the turning point in the epidemic that an automatic death sentence was transformed into a manageable disease. For the past decade and a half, he has shifted his research focus to developing strategies to prevent HIV transmission. He has published more than 500 research papers as of February 2020. And championed the combination anti-retroviral therapy. He is not only a member of Committee of 100, but also leading a team, funded by Jack Ma, to look for a vaccine for the COVID-19 virus. In addition, he has received 14 honorary doctorates, including those from Columbia University and Tsinghua University. In 2001, he was presented with the Presidential Citizens Medal by President Clinton.

dr. Ines Atmosukarto is a biologist, specialized in endophyte microbiology who was born in Rumania in 1972. Currently, she is the CEO and CSO at Lipotek, Canberra and has received several international awards, such as UNESCO-L’Oréal For Women in Science International Fellowships, Australian Alumni Award for Research and Innovation, and IPTEK Award winner in female researcher category. She has Bachelor of Science in Biochemical at University of Adelaide with First Class Honour and Brian and Heather Foster Award. She pursued her higher education and obtained PhD. in Biochemical and Molecular Biology from University of Adelaide with OPRS (Overseas Postgraduate Research Scholarship) and University of Adelaide scholarship in 2001. She returned to Indonesia in 2001 and opened a research laboratory located in Cibinong. In her 3-year-period as a researcher in Indonesia from 2003-2006, she has held the highest role as a scienti? c of? cial at PT. Indo Pertiwi and researched about M2 protein for avian in? uenza that would be a potential vaccine for in? uenza virus A, subtype H5N1.

dr. Ivonne Rampun graduated from Faculity of Medicine, University of Hasanuddin, Makassar and Magister Management, STIE SUPRA Jakarta. She is a professional in the ?eld Medical and Hospital Management with more than 15-year-experience as a Hospital Director in one of the leading hospitals in Indonesia. Reliable in medical management, nursing and also handling medicolegal cases, she currently serves as Director of PT. Bundamedik, Tbk.

I Nyoman Santiawan is the Vice Chairman of Rama Hotels & Resort who has been appointed as member of GIPI Bali (Gabungan Industri Pariwisata Indonesia). Period 2016-2020. He is an entrepreneur that has impacted investor strongly involved with shaping the future of Bali through his signi? cant businesses and work with the Bali Tourism Board. A chosen few of his noteworthy business interests in Bali and beyond within and outside of his family interests, include Ramayana Hotels Bali, Pepito Market
(chain), Raw Kitchen Bali.

Mesha Rizal Sini is currently the Director of PT. Bundamedik, Tbk. He obtained his bachelor degree in Mechanical Engineering at University of Trisakti in 1996 an Master of Engineering Science at University of New South Wales, Australia ini 1999. He started his career as an account manager at PT. Omedata Electric Gajah Tunggal Group, the director PT. Bunda Global Pertama, CV. Buana Sejahtera, and PT. Timur Prima Utama, then as the Commissioner at PT. Tenaga Satu Persada.

Jennifer serves in Temasek Foundation’s leadership team and heads the Philanthropy Advocates Practice. She is responsible for the strategic management of the Foundation’s internal and external communication and engagement activities. Prior to this, she had been with GIC Private Limited for 12 years where she was also managing strategic communications for the sovereign wealth fund. She began her corporate communications journey after more than twenty years as a journalist with television, print and online experience. She also advises several AI and digital asset start-ups. She serves on the Boards of SIM University, Straits Times School Pocket Fund and OnePeople. sg.

Dr. Jon Li completed his Ph. D. in Computer Science from University of Cambridge, specializing in computer graphics, embedded systems and parallel processing. He tries to put real-world cities into Minecraft piqued his interest in making immersive copies of the real world. His research centers on applying the algorithmic lens to interdisciplinary problems. Jon’s interest in semantic modeling of built environments stemmed from a desire to automatically simplify models of real-world landmarks while preserving their iconic features.